| http://www.w3.org/ns/prov#value | - Since the current therapeutic arsenal is of limited impact on HDL-c levels, in particular the most popular medication, such as statins, nonpharmacological measures might deserve more attention, as well as new and more effective agents that might prove efficacy to improve HDL and their beneficial effects, including reduction of Ox-LDL as well as of deleterious inflammatory mediators.
|
